The Value of Gastric Antrum Cross-sectional Area Mearsured by Bedside Ultrasound Predicted Feeding Intolerance in Critically Ill Patients

ZOU Tong-juan, RAN Qi-fang, YIN Wan-hong, XU Yuan, HE Wei, YANG Yi, OU-YANG Bin, ZHU Ran, KANG Yan

Abstract

To explore the feasibility and effectiveness of gastric antrum cross-sectional area (CSA) mearsured by bedside ultrasound for predicting early feeding intolerance (FI) in critically ill patients.  Methods  The data were extracted from a multicenter prospective observation study between February 2018 to December 2018. A bivariate logistic regression model was established to identify the correlation between the gastric antrum cross-sectional area (CSA) and the feeding intolerance (FI). Draw the ROC curve to get the best cut-off value.  Results  This study comprises 150 patients. The mean age was (58.63±16.45) yr., the average APACHE Ⅱ score was 17.43±6.99. The incidence of FI for three days (72 h-FI%) was 28.0%. The multivariate analysis demonstrated that the Day 2 CSA-right lateral decubitus (RLD) was an independent risk factor for FI-day 2 (P=0.033), Day 3 CSA -RLD was an independent risk factor for FI-day 3 (P=0.016). Patients with day 3 CSA-RLD ≥7.092 cm2 had significantly higher rates of FI (P=0.001).  Conclusion  Gastric antrum cross-sectional area measured by ultrasound can predict feeding intolerance during early enteral nutrition. When the Day 3 CSA-RLD is greater than 7.092 cm2, the incidence of feeding intolerance is significantly increased.

 

Keywords: ICU, Ultrasound, Cross-section area, Feed intolerance

 

Full Text:

PDF


References


FRASER R J. BRYANT L. Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. Nutr Clin Pract,2010,25( 1);26-31.

NGUYEN N Q. YI M S. Current issues on safety of prokinetics in critically ill patients with feed intolerance. Ther Adv Drug Saf,2011,2(5): 197-204.

DEANE A, CHAOMAN M J, FRASER R J, et al. Mechanisms underlying feed intolerance in the critically ill; Implications for treatment. World J Gastroenterol, 2007, 13 (29):3909-3917.

NASIRI M, FARSI Z, AHANGARI M et al. Comparison of intermittent and bolus enteral feeding methods on enteral feeding intolerance of patients with sepsis; a triple-blind controlled trial in intensive care units. Middle East J Dig Dis, 2017,9(4);218-227.

MCCLAVE S A, TAYLOR В E, MARTINDALE R G, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine ( SCCM) and American society for parenteral and enteral nutrition (A. S. P. E. N. ). J Parenter Enteral Nutr,2016,40(2): 159-211.

MENTEC H, DUPONT H, BOCCHETTI M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med,2001,29( 10): 1955-1961.

GUNGABISSOON U, HACQUOII- К. BAINS С, et al. Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness. J Parenter Enteral Nutr,2015,39(4);441-448.

BLASERAR, STARKOPF J, KIRSIMAGI U, et al. Definition, prevalence, and outcome of feeding intolerance in intensive care; a systematic review and meta-analysis. Acta Anaesthesiol Scand,2014,58(8) :914-922.

BEAUX D, CHAPMAN M, FRASER R, et al. Enteral nutrition in the critically ill; a prospective survey in an Australian intensive care unit. Anaesth Intensive Care,2001, 29(6):619-622.

NGUYEN N Q, CHAPMAN M, FRASER R J, et al. Prokinetic therapy for feed intolerance in critical illness: one drug or two? Crit Care Med,2007,35(11);2561-2567.

HU B, SUN R, WU A, et al. Prognostic value of prolonged feeding intolerance in predicting all-cause mortality in critically ill patients: a multicenter, prospective, observational study. J Parenter Enteral Nutr, 2019 2019-09- 12]. https://doi.org/10. 1002/jpen. 1693.

HEYLANDDK, VAN ZANTEN A R H. GRAU- CARMONAT, et al. A multicenter, randomized, double-

blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial. Intensive Care Med,2019.45(5);647-656.

ARABI Y M, REINTAM BLASER A. PREISER J C. When and how to manage enteral feeding intolerance, Intensive Care Med,2019 ,45(7) : 1029-1031.

SINGER P, BLASER A R. BERGER M M, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr,2019,38(1) :48-79.

MCCLAVESA, LUKAN J K, STEFATER J A, et al. Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med. 2005, 33 (2):324-330.

CHEN X, CHEN F, ZHAO Q, et al. Ultrasonographic measurement of antral area for estimating gastric fluid volume in pregnant women. J Clin Anesth,2019,53;70-73.

MOORE С L, COPEL J A. Point-of-care ultrasonography. N Engl J Med,2011,104(9) :2075-2076.

VOLPICELLI G, ELBARBARY M. BLAIVAS M, et al. International evidence-based recommendations for point-of- care lung ultrasound. Intensive Care Med,2012,38(4); 577- 591.

LEVITOVA, FRANKEL H L, BLAIVAS M, et al. Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-part 11 : cardiac ultrasonography. Crit Care Med, 2016,44(6);1206-1227.


Refbacks

  • There are currently no refbacks.